The inhibition of mitochondrial fragmentation, either by inhibiting Drp1 via RNAi or overexpressing Mfn1, leads to decreased migration, invasion, and lamellipod formation in breast cancer cell lines [122]. Here, DNM1L is linked to breast carcinoma.